{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:08:26Z","timestamp":1790806106368,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.lfs.2023.121496","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T02:32:15Z","timestamp":1677033135000},"page":"121496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The GSTP1\/MAPKs\/BIM\/SMAC modulatory actions of nitazoxanide: Bioinformatics and experimental evidence in subcutaneous solid Ehrlich carcinoma-inoculated mice"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-2724","authenticated-orcid":false,"given":"Samar","family":"Imbaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen E.","family":"Elkholy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa K.K.","family":"Abdelmaogood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir E.","family":"Mehana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma S.A.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar M.","family":"Abd El-moneam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8464-4051","authenticated-orcid":false,"given":"Samah M.","family":"Elaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.121496_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2023.121496_bb0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2023.121496_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5162687","article-title":"Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice","volume":"2019","author":"Aldubayan","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2023.121496_bb0020","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1523\/JNEUROSCI.22-22-09764.2002","article-title":"Amyloid-\u03b2 induces Smac release via AP-1\/Bim activation in cerebral endothelial cells","volume":"22","author":"Yin","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2023.121496_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/13880209.2013.834365","article-title":"Growth inhibition and apoptosis of ehrlich ascites carcinoma cells by the methanol extract of Eucalyptus camaldulensis","volume":"52","author":"Islam","year":"2014","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2023.121496_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2014.05.007","article-title":"Small-molecule SMAC mimetics as new cancer therapeutics","volume":"144","author":"Bai","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2023.121496_bb0035","doi-asserted-by":"crossref","first-page":"36152","DOI":"10.1074\/jbc.C000533200","article-title":"Molecular determinants of the caspase-promoting activity of Smac\/DIABLO and its role in the death receptor pathway *","volume":"275","author":"Srinivasula","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/OTT.S33375","article-title":"IAP proteins as targets for drug development in oncology","volume":"6","author":"Dubrez","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.lfs.2023.121496_bb0045","doi-asserted-by":"crossref","first-page":"26661","DOI":"10.1016\/S0021-9258(19)61427-4","article-title":"The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7","volume":"275","author":"Huang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0050","first-page":"1251","article-title":"SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1\/TRAF3 signaling pathway","volume":"21","author":"Ding","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2023.121496_bb0055","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1073\/pnas.1005667107","article-title":"Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression","volume":"107","author":"Petersen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.121496_bb0060","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/cdd.2010.44","article-title":"Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-\u03b1-dependent manner","volume":"17","author":"Probst","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121496_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1756-9966-27-48","article-title":"Role of Smac\/DIABLO in cancer progression","volume":"27","author":"Martinez-Ruiz","year":"2008","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0070","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.1002\/jcb.28205","article-title":"Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer","volume":"120","author":"Nikkhoo","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2023.121496_bb0075","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/s41418-020-0541-0","article-title":"Targeting triple-negative breast cancers with the Smac-mimetic birinapant","volume":"27","author":"Lalaoui","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121496_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-012-2352-6","article-title":"Smac mimetic birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-\u03b1-independent mechanism","volume":"137","author":"Allensworth","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lfs.2023.121496_bb0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcp.2012.04.023","article-title":"Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells","volume":"84","author":"Chen","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121496_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01298","article-title":"The SMAC mimetic APG-1387 sensitizes immune-mediated cell apoptosis in hepatocellular carcinoma","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121496_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2015.04.018","article-title":"Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells","volume":"365","author":"Liese","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2023.121496_bb0100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4161\/cbt.20563","article-title":"AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer","volume":"13","author":"Brunckhorst","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2023.121496_bb0105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1535-7163.MCT-13-0798","article-title":"Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-\u03baB activation, and is active in patient-derived xenograft models","volume":"13","author":"Benetatos","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2023.121496_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-016-0435-7","article-title":"LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC","volume":"35","author":"Yang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/hmg\/ddg083","article-title":"A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes","volume":"12","author":"Dai","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.lfs.2023.121496_bb0120","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.3892\/mmr.2014.2625","article-title":"JNK1-mediated phosphorylation of Smac\/DIABLO at the serine 6 residue is functionally linked to its mitochondrial release during TNF-\u03b1\u2013induced apoptosis of HeLa cells","volume":"10","author":"Park","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2023.121496_bb0125","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.1074\/jbc.C300076200","article-title":"JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells","volume":"278","author":"Chauhan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0130","first-page":"342","article-title":"Role of p38 MAP kinase signal transduction in solid tumors","volume":"4","author":"Koul","year":"2013","journal-title":"GenesCancer"},{"key":"10.1016\/j.lfs.2023.121496_bb0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.lfs.2023.121496_bb0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molcel.2004.08.028","article-title":"Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation","volume":"15","author":"Sabapathy","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2023.121496_bb0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/cr.2008.86","article-title":"Induction of apoptosis by shikonin through a ROS\/JNK-mediated process in Bcr\/Abl-positive chronic myelogenous leukemia (CML) cells","volume":"18","author":"Mao","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12906-015-0752-y","article-title":"Electroacupuncture at different frequencies (5Hz and 25Hz) ameliorates cerebral ischemia-reperfusion injury in rats: possible involvement of p38 MAPK-mediated anti-apoptotic signaling pathways","volume":"15","author":"Cheng","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2023.121496_bb0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cncr.22888","article-title":"Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells","volume":"110","author":"Das","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2023.121496_bb0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrclinonc.2014.51","article-title":"Standing the test of time: targeting thymidylate biosynthesis in cancer therapy","volume":"11","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2023.121496_bb0170","doi-asserted-by":"crossref","first-page":"20999","DOI":"10.1074\/jbc.M101355200","article-title":"Glutathione S-transferase P1\u20131 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0175","doi-asserted-by":"crossref","first-page":"30866","DOI":"10.1074\/jbc.M115.656140","article-title":"Phosphorylation of glutathione S-transferase P1 (GSTP1) by epidermal growth factor receptor (EGFR) promotes formation of the GSTP1-c-Jun N-terminal kinase (JNK) complex and suppresses JNK downstream signaling and apoptosis in brain tumor cells *","volume":"290","author":"Okamura","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.968148","article-title":"Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking","volume":"13","author":"Khan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121496_bb0185","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-14-0792","article-title":"Three-dimensional cell culture-based screening identifies the anthelmintic drug nitazoxanide as a candidate for treatment of colorectal cancer","volume":"14","author":"Senkowski","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2023.121496_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mrfmmm.2014.05.005","article-title":"A functional perspective of nitazoxanide as a potential anticancer drug","volume":"768","author":"Di Santo","year":"2014","journal-title":"Mutat. Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0195","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/s41388-019-1142-6","article-title":"Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain","volume":"39","author":"Ripani","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2023.121496_bb0200","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-020-03736-4","article-title":"Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6\/JAK2\/STAT3 and p53\/caspases-dependent signaling pathways based on molecular docking and in vitro study","author":"Tantawy","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2023.121496_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mrfmmm.2014.05.005","article-title":"A functional perspective of nitazoxanide as a potential anticancer drug","volume":"768","author":"Di Santo","year":"2014","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"10.1016\/j.lfs.2023.121496_bb0210","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41419-018-1058-z","article-title":"Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.121496_bb0215","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.3390\/ijms22105213","article-title":"Antitumor activity of nitazoxanide against colon cancers: molecular docking and experimental studies based on Wnt\/\u03b2-catenin signaling inhibition","volume":"22","author":"Abd El-Fadeal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121496_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114588","article-title":"Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer","volume":"190","author":"Sun","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121496_bb0225","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1038\/onc.2011.575","article-title":"Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase\u2013Bim axis and reveals glutathione-S-transferase P1 as Achilles'heel","volume":"31","author":"Sidler","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2023.121496_bb0230","doi-asserted-by":"crossref","first-page":"e1778","DOI":"10.1038\/cddis.2015.137","article-title":"Thiazolides promote apoptosis in colorectal tumor cells via MAP kinase-induced Bim and Puma activation","volume":"6","author":"Brockmann","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.121496_bb0235","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0240","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.lfs.2023.121496_bb0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14756366.2021.2007905","article-title":"Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies","volume":"37","author":"Khalifa","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.lfs.2023.121496_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108485","article-title":"Screening of different drug design tools to predict the mode of action of steroidal derivatives as anti-cancer agents","volume":"152","author":"Nafie","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.lfs.2023.121496_bb0260","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.3390\/molecules25215007","article-title":"Molecular insights into human transmembrane protease Serine-2 (TMPS2) inhibitors against SARS-CoV2: homology modelling,molecular dynamics, and docking studies","volume":"25","author":"Kishk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2023.121496_bb0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12291-013-0343-y","article-title":"Anticancer effect of dl-glyceraldehyde and 2-deoxyglucose in Ehrlich ascites carcinoma bearing mice and their effect on liver, kidney and haematological parameters","volume":"29","author":"Kapoor","year":"2014","journal-title":"IndianJ. Clin. Biochem."},{"key":"10.1016\/j.lfs.2023.121496_bb0270","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7150\/ijbs.5.466","article-title":"Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats","volume":"5","author":"El-Sayyad","year":"2009","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2023.121496_bb0275","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1038\/s41598-018-23669-9","article-title":"Subcutaneous ehrlich ascites carcinoma mice model for studying cancer-induced cardiomyopathy","volume":"8","author":"Mishra","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121496_bb0280","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2023.121496_bb0285","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10620-006-9124-2","article-title":"Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition","volume":"52","author":"Spencer","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.121496_bb0290","doi-asserted-by":"crossref","first-page":"15316","DOI":"10.1038\/s41598-020-72136-x","article-title":"Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis","volume":"10","author":"Imbaby","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121496_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112599","article-title":"Baicalin; a promising chemopreventive agent, enhances the antitumor effect of 5-FU against breast cancer and inhibits tumor growth and angiogenesis in ehrlich solid tumor","volume":"146","author":"Shehatta","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.121496_bb0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12951-019-0445-7","article-title":"Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin\u2013QDs nano-hybrids: covalent coupling and phospholipid complexation approaches","volume":"17","author":"Zayed","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.lfs.2023.121496_bb0305","first-page":"2375","article-title":"Ehrlich ascites carcinoma","volume":"10","author":"Ozaslan","year":"2011","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.lfs.2023.121496_bb0310","first-page":"338","article-title":"Chemoprophylactic activity of nitazoxanide in experimental model of mammary gland carcinoma in rats","volume":"10","author":"Pal","year":"2020","journal-title":"3Biotech"},{"key":"10.1016\/j.lfs.2023.121496_bb0315","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/1535-7163.MCT-12-1243","article-title":"A c-myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide","volume":"12","author":"Fan-Minogue","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2023.121496_bb0320","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3892\/ijo.2015.3298","article-title":"Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing \u03b1-particle radiation","volume":"48","author":"Ponce-Cusi","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2023.121496_bb0325","first-page":"211","article-title":"Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer","volume":"6","author":"Chu","year":"1996","journal-title":"J. Infus. Chemother."},{"key":"10.1016\/j.lfs.2023.121496_bb0330","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.3390\/ijms22105213","article-title":"Antitumor activity of nitazoxanide against colon cancers: molecular docking and experimental studies based on Wnt\/\u03b2-catenin signaling inhibition","volume":"22","author":"Abd El-Fadeal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121496_bb0335","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.121496_bb0340","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4161\/onci.20369","article-title":"The role of SMAC mimetics in regulation of tumor cell death and immunity","volume":"1","author":"Emeagi","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lfs.2023.121496_bb0345","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.7150\/thno.33758","article-title":"Modulation of respiration and mitochondrial dynamics by SMAC-mimetics for combination therapy in chemoresistant cancer","volume":"9","author":"Hagenbuchner","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2023.121496_bb0350","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1182\/blood-2006-05-021675","article-title":"XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack","volume":"108","author":"Kashkar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2023.121496_bb0355","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3892\/mmr.2013.1842","article-title":"Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy","volume":"9","author":"Zhao","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2023.121496_bb0360","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/1078-0432.CCR-11-0426","article-title":"Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma","volume":"17","author":"Xu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03232-z","article-title":"Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic birinapant","volume":"11","author":"Fichtner","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.121496_bb0370","first-page":"8019","article-title":"Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells","volume":"15","author":"Dai","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2023.121496_bb0375","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1038\/sj.cdd.4401437","article-title":"Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs","volume":"11","author":"Ganten","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121496_bb0380","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/cdd.2010.19","article-title":"TNF-\u03b1-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL","volume":"17","author":"Kim","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121496_bb0385","first-page":"3579","article-title":"Role of caspases in 5-FU and selenium induced growth inhibition of colorectal cancer cells","volume":"28","author":"Thant","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0390","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.lfs.2023.121496_bb0395","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrm2434","article-title":"Cytochrome c: functions beyond respiration","volume":"9","author":"Ow","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2023.121496_bb0400","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/onc.2011.508","article-title":"Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression","volume":"31","author":"M\u00e9rino","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2023.121496_bb0405","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/blood-2009-03-209544","article-title":"Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells","volume":"115","author":"Will","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2023.121496_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013026","article-title":"Apoptosis induction by MEK inhibition in human lung cancer cells is mediated by Bim","volume":"5","author":"Meng","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2023.121496_bb0415","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1158\/0008-5472.CAN-10-2954","article-title":"PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression","volume":"71","author":"Paraiso","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/01902148.2015.1125970","article-title":"The apoptotic effect of simvastatin via the upregulation of BIM in nonsmall cell lung cancer cells","volume":"42","author":"Lee","year":"2016","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0425","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1038\/onc.2011.111","article-title":"Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification","volume":"30","author":"Tanizaki","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2023.121496_bb0430","series-title":"Adv. Pharmacol","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/B978-0-12-397927-8.00016-6","article-title":"Apoptosis in targeted therapy responses","author":"Faber","year":"2012"},{"key":"10.1016\/j.lfs.2023.121496_bb0435","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2018.11.004","article-title":"BH3-mimetic drugs: blazing the trail for new cancer medicines","volume":"34","author":"Merino","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.lfs.2023.121496_bb0440","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2023.121496_bb0445","series-title":"Mitogen-activated Protein Kinases (MAPK) in Cancer","first-page":"472","author":"Cuenda","year":"2019"},{"key":"10.1016\/j.lfs.2023.121496_bb0450","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.lfs.2023.121496_bb0455","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ijc.23755","article-title":"Thiazolides inhibit growth and induce glutathione- S -transferase Pi (GSTP1)-dependent cell death in human colon cancer cells","volume":"123","author":"M\u00fcller","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121496_bb0460","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/gast.2001.27982","article-title":"Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis","volume":"121","author":"Miyanishi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121496_bb0465","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.urolonc.2008.10.019","article-title":"Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways","volume":"29","author":"Pljesa-Ercegovac","year":"2011","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.lfs.2023.121496_bb0470","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/s41418-019-0276-y","article-title":"Glutathione S-transferases P1 protects breast cancer cell from adriamycin-induced cell death through promoting autophagy","volume":"26","author":"Dong","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121496_bb0475","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.bjc.6602681","article-title":"Combined effects of GSTP1 and MRP1 in melanoma drug resistance","volume":"93","author":"Depeille","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121496_bb0480","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1349-7006.2012.02231.x","article-title":"GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer","volume":"103","author":"Miyake","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2023.121496_bb0485","first-page":"2050","article-title":"miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells","volume":"41","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2023.121496_bb0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjc.6602891","article-title":"Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) \u2013 novel predictors for response and survival in gastric cancer patients","volume":"94","author":"Goekkurt","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121496_bb0495","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/cdd.2010.80","article-title":"Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death","volume":"17","author":"Laborde","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.121496_bb0500","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/895381","article-title":"TJ-41 induces apoptosis and potentiates the apoptotic effects of 5-FU in breast cancer cell lines","volume":"2009","author":"Volate","year":"2009","journal-title":"J. Oncol."},{"key":"10.1016\/j.lfs.2023.121496_bb0505","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:34:18Z","timestamp":1736382858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":101,"alternative-id":["S0024320523001303"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121496","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The GSTP1\/MAPKs\/BIM\/SMAC modulatory actions of nitazoxanide: Bioinformatics and experimental evidence in subcutaneous solid Ehrlich carcinoma-inoculated mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121496"}}